
    
      By conducting large sample, multicenter, double-blind, randomized comparison clinical
      research, this test will investigate the effects of fufang E'Jiao Jiang intervening
      cancer-related fatigue (CRF) with deficiency of qi and blood, under the guidance of its
      specification. This test choose the improvement of fatigue degree as key indicator, and
      choose the improvement both symptoms of patients and quality of life as second indicators.
      And last, the study will try to verify its safety and efficacy with some haematological
      indexs and reveal its mechanism from the perspectives of hormone, immune and metabonomics, so
      as to explore the advantages of traditional Chinese medicine（TCM） in the treatment of CRF and
      support some high quality, internationally recognized clinical evidence.
    
  